阮杨, 魏欣, 李群, 金泽宁. 血小板参数对急性心力衰竭患者预后的预测价值[J]. 心脏杂志, 2023, 35(5): 552-556, 569. DOI: 10.12125/j.chj.202212079
    引用本文: 阮杨, 魏欣, 李群, 金泽宁. 血小板参数对急性心力衰竭患者预后的预测价值[J]. 心脏杂志, 2023, 35(5): 552-556, 569. DOI: 10.12125/j.chj.202212079
    Yang RUAN, Xin WEI, Qun LI, Ze-ning JIN. Prognostic value of platelet parameters in patients with acute heart failure value[J]. Chinese Heart Journal, 2023, 35(5): 552-556, 569. DOI: 10.12125/j.chj.202212079
    Citation: Yang RUAN, Xin WEI, Qun LI, Ze-ning JIN. Prognostic value of platelet parameters in patients with acute heart failure value[J]. Chinese Heart Journal, 2023, 35(5): 552-556, 569. DOI: 10.12125/j.chj.202212079

    血小板参数对急性心力衰竭患者预后的预测价值

    Prognostic value of platelet parameters in patients with acute heart failure value

    • 摘要:
        目的  探讨血小板参数对急性心力衰竭(acute heart failure,AHF)患者预后的预测价值。
        方法  选取2019年5月~2022年5月于首都医科大学附属北京天坛医院收治的AHF患者500例作为研究对象,根据其预后情况分为预后不良组(n=125)和预后良好组(n=375)。比较两组患者一般资料、实验室检查指标及血小板参数差异,相关性分析采用Pearson进行分析,影响因素采用多元Logistic回归模型分析,模型区分度和准确度采用ROC与校准曲线评价。
        结果  随访6个月,预后不良组年龄、心率、NYHA分级Ⅳ级比例、HFrEF比例、HFmrEF比例、NT-proBNP、LVESD、LVEDD、血乳酸、Cys-C、hs-CRP、PDW、MPV数据较预后良好组显著增加(均P < 0.01),而脑卒中比例、心房颤动比例、BMI、收缩压、心衰HFpEF 、LVEF、血红蛋白数据显著低于预后良好组(均P < 0.01);多元Logistic回归模型结果表明NT-proBNP、年龄、NYHA分级、血乳酸、PDW、MPV是影响AHF患者预后的独立危险因素,而LVEF、血红蛋白是保护因素(均P<0.05);Pearson相关分析表明PDW、MPV表达水平分别与LVEF呈负相关(r=−0.231,r=−0.408,P=0.032,P=0.006);绘制ROC曲线显示,血小板参数PDW、MPV单独检测时,AUC分别为0.801、0.761,两项指标联合检测时AUC为0.854(95%CI:0.801~0.893);最后基于其关键因素进行列线图预测模型构建,回归方程Logit(P)=−2.541+0.257*X1−0.226*X2+0.512*X3+0.436*X4-0.234*X5+0.306*X6+0.518*X7+0.641*X8;ROC曲线和校准曲线结果显示该预测模型具有良好的区分度和准确度。
        结论  血小板参数与AHF患者预后关系密切,其中PDW、MPV均是AHF患者预后不良的关键因素,且二者联合检测能提高其预后不良的诊断效能。

       

      Abstract:
        AIM   To explore the predictive value of platelet parameters on the prognosis of patients with acute heart failure (AHF).
        METHODS  500 patients with AHF who were admitted to Beijing Tiantan Hospital affiliated to Capital Medical University from May 2019 to May 2022 were selected as the study subjects. According to their prognosis, they were divided into poor prognosis group (n=125) and good prognosis group (n=375). Compare the differences between the two groups in general data, laboratory test indicators and platelet parameters. Pearson was used for correlation analysis, multiple logistic regression model was used for analysis of influencing factors, and ROC and calibration curve were used for evaluation of model differentiation and accuracy.
        RESULTS   After 6 months of follow-up, the age, heart rate, NYHA grade IV ratio, HFrEF ratio, HFmrEF ratio, NT-proBNP, LVESD, LVEDD, blood lactic acid, Cys-C, hs-CRP, PDW, MPV data of the poor prognosis group were significantly higher than those of the good prognosis group (all P<0.01), while the stroke ratio, atrial fibrillation ratio, BMI, systolic blood pressure, heart failure HFpEF, LVEF, hemoglobin data were significantly lower than those of the good prognosis group (all P<0.01); The results of multiple logistic regression model showed that NT-proBNP, age, NYHA grade, blood lactic acid, PDW and MPV were independent risk factors affecting the prognosis of AHF patients, while LVEF and hemoglobin were protective factors (all P<0.05); Pearson correlation analysis showed that the expression levels of PDW and MPV were negatively correlated with LVEF (r=−0.231, r=−0.408, P=0.032, P=0.006); The ROC curve showed that the AUC of platelet parameters PDW and MPV were 0.801 and 0.761 respectively when tested separately, and 0.854 (95% CI: 0.801~0.893) when tested jointly; Finally, the nomograph prediction model is constructed based on its key factors. The regression equation Logit (P)=−2.541+0.257*X1−0.226*X2+0.512*X3+0.436*X4−0.234*X5+0.306*X6+0.518*X7+0.641*X8; The ROC curve and calibration curve results show that the prediction model has good discrimination and accuracy.
        CONCLUSION  Platelet parameters are closely related to the prognosis of AHF patients. PDW and MPV are risk factors for poor prognosis of AHF patients, and their combined detection can improve the diagnostic efficacy of poor prognosis.

       

    /

    返回文章
    返回